Saltar al contenido principal
Pan y Hierro Nutrition and exercise with sources

Blog

Vitamin D: why supplementing everyone does not hold up in the trials

What randomized trials and Mendelian randomization show about vitamin D, the 2011 DRI, and in which groups there is documented benefit.

Large trials and meta-analyses have been published on vitamin D, and the score is not the one that was expected. The reason for that disappointment is interesting, and it lies in the design of the studies.

What the trials and Mendelian randomization say

A 2023 review summarizes the results of large randomized trials (RCTs) and of Mendelian randomization studies on vitamin D in bone health, fractures, falls, cancer, cardiovascular disease, immune disorders, multiple sclerosis and mortality [1].

Its main analysis is a list of absences, and it has to be read as such:

  • Vitamin D supplementation did not reduce bone loss [1].
  • It did not reduce fractures [1].
  • It did not reduce falls [1].

And then there are the findings in favor, which the review itself also lists: the large trials and meta-analyses suggest an effect of supplemental vitamin D on cancer mortality, with the benefit in people taking daily doses and not in isolated large doses [1].

All-cause mortality is the case that needs to be bounded, because the review does not take it as established. The figure it cites is from a 2014 Cochrane review: about 75,000 people in 38 trials, with a modest reduction in mortality, around 6% [1]. But that figure comes from old trials with more participants deficient in vitamin D, and the review itself points out that recent trials, with more than 50,000 mostly well-nourished adults, found no overall effect on mortality [1]. The Mendelian randomization studies, on top of that, are inconsistent: three with no association, two with a modest benefit, and the set of all five, when reanalyzed, did not hold up [1]. That is why here we talk about signals and not about demonstrated reduction.

The key is in a sentence, not in a headline

The article closes with the clarification that is almost never quoted: these findings, in populations generally well nourished in vitamin D, **are not applicable to older people living in residential communities nor to adults with

The conclusion is explicit: the focus of supplementation should move from generalized use in the healthy population to supplementation targeted at specific people, to better nutritional approaches and to eliminating vitamin D deficiency at a global level [1].

Why the study design explains so much

The review itself explains the methodological problem behind it: observational studies on vitamin D and musculoskeletal and non-musculoskeletal outcomes may be confounded by reverse causality [1]. In other words, it may not be vitamin D that prevents the disease, but rather that healthy, active people (those who exercise more outdoors and eat a better diet) also have more vitamin D.

Randomized trials and Mendelian randomization, which use genetics as a natural instrument, do allow getting closer to causality, and their result is considerably less favorable [1].

The reference figure

The Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine (National Academies), published in 2011, is the consensus report that sets the intake references for calcium and vitamin D. The context it provides is simple: vitamin D is synthesized in the skin through exposure to sunlight and is also supplied by the diet [2]. The report includes among its groups of interest those living at high latitudes, those with lower sun synthesis, people

In summary

  1. In a healthy and well-nourished population, randomized trials show no benefit from supplementation on bone, fractures, falls, cancer or cardiovascular risk [1].
  2. There are signals of an effect on cancer mortality, with daily doses and not with isolated large doses. On all-cause mortality, there is only a modest reduction, around 6%, in old trials with more deficient participants: recent trials in well-nourished adults did not find it [1].
  3. The non-skeletal benefit is better documented in people with low vitamin D status, with autoimmune diseases or with multiple sclerosis, especially against respiratory infections [1].
  4. The positive observational evidence can be explained by reverse causality [1], and that is why the trials weigh more.

This article is not a recommendation to supplement or not to supplement. If you are pregnant, have osteoporosis or an autoimmune disease, your healthcare professional decides the dose and the need.

More at: the supplements page, with the figures and the sources from the Nutrition section.

with dark skin and those who use sunscreen, as well as indoor environments and institutionalized older adults [2]. Its requirements are estimated assuming minimal sun exposure, because public health rules out setting them based on the sun due to the skin cancer risk [2].

Where it fits with the rest of the diet

The WHO healthy diet fact sheet does not set a daily amount of vitamin D [3]. What it does do is fit vitamin D into the whole picture: a healthy diet is based on minimally processed or unprocessed foods, low in unhealthy fats, free sugars and sodium [3].

vitamin D deficiency or osteoporosis** [1].

There is the whole story in two lines:

Where it fits with the rest of the diet: Population · What the data show
Population What the data show
Healthy adults living in the community with adequate vitamin D status No benefit in bone, fractures, falls, cancer or cardiovascular risk [1]
People with low vitamin D status, autoimmune diseases and multiple sclerosis The non-skeletal effect is better documented, especially for respiratory infections [1]
  • It did not reduce cancer incidence [1].
  • It did not reduce hypertension or cardiovascular risk [1].

Related articles

Sources for this article (3) 3 references
  1. Bouillon R, LeBoff MS, Neale RE, Bikle DD (2023) Health Effects of Vitamin D Supplementation: Lessons Learned From Randomized Controlled Trials and Mendelian Randomization Studies. Journal of Bone and Mineral Research 38(10). See source (opens in a new tab) DOI: 10.1002/jbmr.4888 Revisión de ensayos aleatorizados y estudios de aleatorización mendeliana Licence: Artículo de revista disponible en PubMed Central, con derechos de autor (sin licencia libre). Se cita con enlace; no se reproduce texto salvo cita breve verificable. Consulted:
  2. Institute of Medicine (IOM, National Academies) (2011) Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press, Washington, DC. See source (opens in a new tab) Informe de consenso del Institute of Medicine (DRI de calcio y vitamina D) Licence: Obra del Gobierno de los Estados Unidos (dominio público). Descarga gratuita en nap.edu. Consulted:
  3. Organización Mundial de la Salud (OMS) (2026) Healthy diet — hoja de datos. Organización Mundial de la Salud (OMS). See source (opens in a new tab) Hoja de datos de la OMS (recomendaciones de salud pública) Licence: OMS: el contenido de esta web está disponible bajo licencia CC BY-NC-SA 3.0 IGO. Se cita con enlace. Consulted:

How to cite

Pan y Hierro (2026). Vitamin D: why supplementing everyone does not hold up in the trials. https://panyhierro.com/en/blog/vitamin-d-why-supplementation-for-everyone/. Updated October 3, 2026.